(Q42210564)

English

Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: a comparative observational study

scientific article published on 13 June 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: a comparative observational study (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

toxic shock syndrome

1 reference

based on heuristic

inferred from title

Anna Norrby-Teglund

5

object named as

Anna Norrby-Teglund

0 references

author name string

Anna Linnér

1

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Jessica Darenberg

2

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Jan Sjölin

3

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Birgitta Henriques-Normark

4

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Anna Norrby-Teglund

5

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

language of work or name

0 references

publication date

13 June 2014

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Clinical Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

59

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

851-857

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

The global burden of group A streptococcal diseases

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU449

21 January 2018

Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU449

21 January 2018

Toxic shock syndrome and bacterial superantigens: an update

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU449

21 January 2018

Getting under the skin: the immunopathogenesis of Streptococcus pyogenes deep tissue infections

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU449

21 January 2018

Toxic shock syndrome: major advances in pathogenesis, but not treatment

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU449

21 January 2018

Molecular basis of group A streptococcal virulence

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU449

21 January 2018

M protein, a classical bacterial virulence determinant, forms complexes with fibrinogen that induce vascular leakage

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU449

21 January 2018

Streptococcal M protein: a multipotent and powerful inducer of inflammation

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU449

21 January 2018

Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens [see comment]

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU449

21 January 2018

Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU449

21 January 2018

Intravenous immunoglobulin in children with streptococcal toxic shock syndrome

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU449

21 January 2018

Assessing the impact of intravenous immunoglobulin in the management of streptococcal toxic shock syndrome: a noble but difficult quest

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU449

21 January 2018

Successful management of severe group A streptococcal soft tissue infections using an aggressive medical regimen including intravenous polyspecific immunoglobulin together with a conservative surgical approach.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU449

21 January 2018

Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU449

21 January 2018

Early diagnosis, nutritional support, and immediate extensive debridement improve survival in necrotizing fasciitis

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU449

21 January 2018

Molecular and clinical characteristics of invasive group A streptococcal infection in Sweden.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU449

21 January 2018

Invasive group A streptococcal infections in Florida

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU449

21 January 2018

A survey of physician's attitudes regarding management of severe group A streptococcal infections.

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU449

21 January 2018

The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU449

21 January 2018

An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU449

21 January 2018

Identifiers

10.1093/CID/CIU449

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42210564&oldid=1936005286"